Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1467652/000110465918063669/a18-37025_18k.htm
March 2021
February 2021
January 2021
December 2020
December 2020
December 2020
November 2020
August 2020
June 2020
June 2020
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1467652/000110465918063669/a18-37025_18k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Neos Therapeutics, Inc..
Neos Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Neos Therapeutics, Inc. provided additional information to their SEC Filing as exhibits
Ticker: NEOSEvents:
CIK: 1467652
Form Type: 8-K Corporate News
Accession Number: 0001104659-18-063669
Submitted to the SEC: Wed Oct 24 2018 4:16:02 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Tuesday, October 23, 2018
Industry: Pharmaceutical Preparations